Forecast 2023
¥0.00
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
¥0.00
Forecast 2030
TopGraphs Quality Ranking
Underperform
Stock Value
Company Info
P/E
0.00
Beta
0.01
Price-to-book Ratio
1.79
Market Cap
101.71B
TEV
143.19 B
Dividend
¥19.98
Div Yld
2.50%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥1,842.86
Industry
Country
Website
JCR Pharmaceuticals Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
JCR Pharmaceuticals Stock Forecast 2023
¥1,500.00
In the last five quarters, JCR Pharmaceuticals’s Price Target has fallen from ¥3,327.06 to ¥1,842.86 - a -44.61% decrease.
87.73%
Last update: 05/10/2024
Highest Price Target ¥2,000.00
Average Price Target ¥1,500.00
Lowest Price Target ¥1,200.00
JCR Pharmaceuticals Stock Prediction 2025
JCR Pharmaceuticals Stock Forecast 2030
P/E
0.00
Beta
0.01
Price-to-book Ratio
1.79
Market Cap
101.71B
TEV
143.19 B
Dividend
¥19.98
Div Yld
2.50%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥1,842.86
Industry
Country
Website
JCR Pharmaceuticals Analyst Ratings Frequently Asked Questions
Who are the analysts watching JCR Pharmaceuticals Co., Ltd.?
The following analysts have recently covered JCR Pharmaceuticals:
Citigroup Inc
Citigroup Inc. Research
Daiwa Securities Co. Ltd.
Ichiyoshi Research Institute Inc.
Jefferies LLC
Marktfeld
Mizuho Securities Co., Ltd.
Morgan Stanley
Nomura Securities Co. Ltd.
UBS Investment Bank
(This information refers to the last 90 days.)
Who are the sell-side analysts watching JCR Pharmaceuticals Co., Ltd.?
The following sell-side analysts have recently covered JCR Pharmaceuticals:
Yamaguchi, Hidemaru
Hashiguchi, Kazuaki
Yamazaki, Kiyokazu
Barker, Stephen
Paraskevopoulos, Michail
Tsuzuki, Shinya
Muraoka, Shinichiro
Shigemura, Kyoichiro
Haruta, Kasumi
(This information refers to the last 90 days.)
